» Articles » PMID: 20232771

A New Symptom-based Questionnaire for Predicting the Presence of Asthma

Overview
Date 2010 Mar 18
PMID 20232771
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early diagnosis and treatment of asthma is important for improving health and minimizing the social and economic burden of the disease. A simple questionnaire would provide a convenient and timesaving tool to help physicians diagnose asthma.

Objective: The senior author developed a simple, pre-interview screening questionnaire--the Asthma Screening Questionnaire (ASQ)--consisting of 6 questions. The present report provides performance evidence that the ASQ is a reliable instrument for diagnosing asthma in adults.

Methods: Participants were asthmatics or controls, aged 18 to 65 years. All participants completed the questionnaire (self-administered and physician-administered), and underwent spirometry and a methacholine challenge test (if there was no reversibility during initial spirometry). Sensitivity, specificity, and positive and negative predictive values were calculated for each question, and the total scores of asthmatics were compared with those of controls. The degree of agreement between the self-administered and the physician-administered questionnaire was calculated.

Results: The main symptoms discriminating asthmatics from controls were cough more than average (88% vs 0%), cough from chest (72% vs 0%), shortness of breath with exercise (84% vs 16%), and chest tightness when lying down (72% vs 4%). A cutoff point of total score > or = 4 was associated with the highest combination of sensitivity (96%) and specificity (100%). Substantial agreement was observed between the self-administered and the physician-administered questionnaire (kappa statistic, 0.56-1.00; P<.0001).

Conclusions: The ASQ is a simple, inexpensive, and efficient pre-interview screening tool to diagnose asthma.

Citing Articles

Validation of the adult asthma epidemiological score: a secondary analysis of the EPI-ASTHMA population-based study.

Laranjeira C, Jacome C, Amaral R, Bernardo F, Correia-de-Sousa J, Fonseca J BMJ Open. 2024; 14(11):e086493.

PMID: 39488415 PMC: 11867667. DOI: 10.1136/bmjopen-2024-086493.


Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis.

Bierbrier J, Gerstein E, Whitmore G, Vandemheen K, Bergeron C, Boulet L Chest. 2024; 166(6):1296-1308.

PMID: 39242078 PMC: 11638540. DOI: 10.1016/j.chest.2024.07.183.


Developing Climate Change and Health Impact Monitoring with eHealth at the South East Asia Community Observatory and Health and Demographic Surveillance Site, Malaysia (CHIMES).

Barteit S, Colmar D, Nellis S, Thu M, Watterson J, Gouwanda D Front Public Health. 2023; 11:1153149.

PMID: 38125843 PMC: 10732307. DOI: 10.3389/fpubh.2023.1153149.


Anticipating undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry: a decision tool for bronchial challenge testing.

Shin S, Whitmore G, Boulet L, Boulay M, Cote A, Bergeron C BMC Pulm Med. 2023; 23(1):496.

PMID: 38071285 PMC: 10709915. DOI: 10.1186/s12890-023-02806-9.


Validation of the Arabic Version of the European Community Respiratory Health Survey Screening Questionnaire.

AlShareef S J Asthma Allergy. 2023; 16:735-742.

PMID: 37492585 PMC: 10364826. DOI: 10.2147/JAA.S421175.